Načítá se...
Annexin A2: A tPA Amplifier for thrombolytic stroke therapy
Hemorrhagic transformation, incomplete reperfusion, neurotoxicity, and the short treatment time window comprise major challenges for thrombolytic therapy. Improving tPA therapy has become one of highest priorities in the stroke field. Recent efforts have been aimed at identifying new strategies that...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2994255/ https://ncbi.nlm.nih.gov/pubmed/20876506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.110.596106 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|